BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1983381)

  • 21. Different haplotypes for cystic fibrosis-linked DNA polymorphisms in Polish and Dutch populations.
    Maciejko D; Bal J; Mazurczak T; te Meerman G; Buys C; Oostra B; Halley D
    Hum Genet; 1989 Oct; 83(3):220-2. PubMed ID: 2571559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A candidate for the cystic fibrosis locus isolated by selection for methylation-free islands.
    Estivill X; Farrall M; Scambler PJ; Bell GM; Hawley KM; Lench NJ; Bates GP; Kruyer HC; Frederick PA; Stanier P
    Nature; 1987 Apr 30-May 6; 326(6116):840-5. PubMed ID: 2883581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The application of molecular genetics to the study of the basic defect causing cystic fibrosis.
    Estivill X; Bates G; Bell G; Farrall M; Frederick P; Hawley K; Kruyer H; Lench N; Scrambler P; Stanier P
    Prog Clin Biol Res; 1987; 254():181-90. PubMed ID: 2893385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of DNA probes for the prenatal diagnosis of cystic fibrosis.
    Dry PJ; Wake S; Robertson CF; Colley P; Sheffield LJ
    Med J Aust; 1989 Aug; 151(3):131, 133-6. PubMed ID: 2569157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of linkage disequilibrium between different cystic fibrosis mutations and three intragenic microsatellites in the Italian population.
    Russo MP; Romeo G; Devoto M; Barbujani G; Cabrini G; Giunta A; D'Alcamo E; Leoni G; Sangiuolo F; Magnani C
    Hum Mutat; 1995; 5(1):23-7. PubMed ID: 7537148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of various polymorphic markers of the CFTR gene in cystic fibrosis patients and healthy donors from the Moscow region].
    Amosenko FA; Sazonova MA; Kapranov NI; Trubnikova IS; Kalinin VN
    Genetika; 1995 Apr; 31(4):532-5. PubMed ID: 7607440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA analysis of cystic fibrosis genotypes in relatives with equivocal sweat test results.
    Amos JA; Janes SR; Erbe RW
    Clin Invest Med; 1990 Feb; 13(1):1-5. PubMed ID: 2311311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis.
    Kerem BS; Buchanan JA; Durie P; Corey ML; Levison H; Rommens JM; Buchwald M; Tsui LC
    Am J Hum Genet; 1989 Jun; 44(6):827-34. PubMed ID: 2567116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular approaches to the cystic fibrosis gene.
    Tsui LC; Plavsic N; Markiewicz D; Zsiga M; Kennedy D; Zengerling S; Geller C; Hajjar Z; Kuper S; Panak H
    Prog Clin Biol Res; 1987; 254():73-87. PubMed ID: 2893386
    [No Abstract]   [Full Text] [Related]  

  • 30. Linkage of the DNA-segment D7S13 (pB79a) with the cystic fibrosis locus.
    Böhm D; Krawczak M; Schmidtke J
    Hum Genet; 1988 Feb; 78(2):186-7. PubMed ID: 2892783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linkage disequilibrium between cystic fibrosis and linked DNA polymorphisms at two DNA markers, XV-2c and KM. 19, in North African families.
    Lucotte G; Barré E; David F
    Am J Hum Genet; 1989 Oct; 45(4):635-7. PubMed ID: 2491019
    [No Abstract]   [Full Text] [Related]  

  • 32. Origin and diffusion of the major CF mutation in Europe. The European Working Group on CF Genetics (EWGCFG).
    Devoto M
    Adv Exp Med Biol; 1991; 290():63-71; discussion 71-4. PubMed ID: 1950758
    [No Abstract]   [Full Text] [Related]  

  • 33. Expected behavior of conditional linkage disequilibrium.
    Kaplan N; Weir BS
    Am J Hum Genet; 1992 Aug; 51(2):333-43. PubMed ID: 1353663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting the range of linkage disequilibrium.
    Ott J
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):2-3. PubMed ID: 10618359
    [No Abstract]   [Full Text] [Related]  

  • 35. Toward a geographical history of the predominant and secondary mutations in Europe.
    Serre JL
    Adv Exp Med Biol; 1991; 290():55-62. PubMed ID: 1683102
    [No Abstract]   [Full Text] [Related]  

  • 36. Distribution of RFLP haplotypes in CF in relation to clinical course.
    Gedschold J; Brückner R; Szibor R; Steinbicker V; Berger W; Grade K; Coutelle C; Bauer I; Bittorf T; Brock J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):115-6. PubMed ID: 1983381
    [No Abstract]   [Full Text] [Related]  

  • 37. New restriction fragment length polymorphism (probe E9) reveals the highest linkage disequilibrium in Italian CF patients.
    Devoto M; De Benedetti L; Ronchetto P; Romano L; Romeo G; Tsui LC; Dean M; Collins F; Seia M; Piceni Sereni L
    Acta Univ Carol Med (Praha); 1990; 36(1-4):102-4. PubMed ID: 1983379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional distribution of cystic fibrosis linked DNA haplotypes in Italy, a collaborative study.
    Gasparini P; Cappello N; Dallapiccola B; Devoto M; Estivill X; Ferrari M; Leoni G; Novelli G; Piazza A; Pignatti PF
    Gene Geogr; 1990 Apr; 4(1):53-64. PubMed ID: 1980604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Linkage disequilibrium and DNA markers associated with the gene for cystic fibrosis].
    Ferec C; Verlingue C; Parent P
    J Genet Hum; 1989 Dec; 37(4-5):407-23. PubMed ID: 2635718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis of cystic fibrosis based on restriction fragment length polymorphism of DNA].
    Burg K; Endreffy E; Berekk I; Gyurkovits K; László A; Petri I; Kaiser G; Raskó I
    Orv Hetil; 1987 Dec; 128(49):2571-2, 2575. PubMed ID: 3325874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.